The mammalian liver contains steroid sensitive processes e.g. the production of alpha-2-globulin in the mouse (Roy et al., 1974) or the production of sex hormone binding globulin in the human (Anderson, 1974) , but it is only recently that steroid hormone receptors have been identified in liver parenchyma. Oestrogen (Aten et al., 1978; Porter et al., 1983a) , androgen (Levinson & Decker, 1985; Bannister et al., 1985a) and glucocorticoid receptors (Bojar et al., 1980) have been identified in both human and rodent liver. This recent finding of steroid hormone receptors has prompted research into their potential role in known hormone related liver disease; both oestrogen (ER) and androgen (AR) receptors have been implicated in hepatic tumour production (Farrell et al., 1973; HernandezNieto et al., 1977; Francavilla et al., 1984) and are thought to be intimately involved in the regeneration of rat liver following trauma (Fisher et al., 1984) .
The present study investigated the effect of diethylnitrosamine (DEN) administration, a known hepatic carcinogen, on the AR concentration of male and female rat liver. Although this is a well established model of hepatic carcinogenesis, producing tumours in both female and male animals, no measurements of steroid hormone receptor levels have been reported until now.
The rats used in the experiments were Wistar strain bred in the University of Sheffield Zoology Department. All rats were 9 weeks old at the start of the experiment.
DEN was incorporated in drinking water (5mg 100 ml-1) and offered ad libitum for up to 16 weeks. Groups were sacrificed after 8 or 16 weeks of DEN treatment. Control rats were given normal drinking water, All rats were allowed free access to a standard laboratory diet. Buffers consisted of (i) Tris (10 mmol -1),
EDTA (lmmoll-1), Na2MoO4 (10mmoll-1) and dithiothreitol (1mmoll-1) (TEDGM buffer).
Dithiothreitol was stored as a 0.5 mol 1-solution and added just prior to use; and (ii) Tris (10 mmol I-1) and EDTA (1 mmol I 1) (TE buffer). Rats were sacrificed by cervical dislocation. The liver was rapidly removed and chilled. Portions were either used immediately or snap frozen and stored at -70°C until analysis.
All procedures were performed at 0-4°C. Tissue was finely cut, suspended in TEDGM buffer, 1:8 (w/v) and homogenized on a Ystral homogenizer. Phase contrast microscopy after the final homogenization showed intact nuclei but disruption of the cytosolic envelope. The homogenate was centrifuged at 800 g for 20 min. The supernatant was further centrifuged at 100,000g for 1 h to yield the cytosol. Contamination by lipids was avoided at all stages of cytosol preparation.
Cytosol (400 p1) was incubated, in triplicate, with [3H]-mibolerone at a single saturating concentration, 10nmoll-1 (Bannister et al., 1985b) . Paired samples were incubated in the presence of a 200-fold excess of unlabelled mibolerone. A 1000-fold excess of triamcinolone acetonide was added to all tubes to block cross reactivity of mibolerone to progesterone and hydrocortisone receptors (Asselin et al., 1979; Bannister et al., 1985b) . Cytosol fractions were incubated for 18 h, by which time maximum binding was stable.
Receptors were assayed by the method of Pavlick and Coulson (1976) as modified by Erdos and Bessada (1979 (Bradford, 1976) . Intra-assay coefficient of variation for a single saturating dose analysis of rat liver was 10.1% and interassay coefficient of variation for rat liver, 12%. The lower detection limit of the assay was 4 fmol mg-I protein.
All data are presented as means + s.e. and the significances of the differences between two means was tested by unpaired Student's t-tests.
Histological examination showed that extensive dysplastic changes occurred in all groups of rats fed DEN. The degree of dysplasia was correlated with the time of exposure to DEN; rats fed DEN for 16 weeks had more marked dysplastic changes. Frank macroscopic tumours occurred in a minority of animals but these were excluded from analysis. Androgen receptor levels were significantly higher in the control rats (n =I1) compared with the nitrosamine treated (n=11) male rat livers: 17.4+2.17 vs. 6.33 + 1.15 fmol mg-protein; P < 0.005 ( Figure  la) . No correlation was found between the duration of DEN treatment, the degree of dysplastic change and the fall in AR concentration. No difference in protein concentration was noted between control and DEN treated animals. In the female rats no significant difference was found between the control (n = 16) and nitrosamine treated (n= 13) rats: 5.28+1.98 vs. 6.6+1.15fmolmg-' protein; P<0.6 (Figure lb) . Tissue AR concentrations were significantly lower in the female rats than in the male control groups, P<0.001.
The present study is the first to investigate AR levels in experimentally induced liver carcinogenesis. Our findings are in contrast to the data from AR studies in established human hepatocellular carcinomas. Iqbal et al. (1983) showed the presence of raised AR levels in 4 cases of hepatocellular carcinoma but failed to show binding in normal liver. Subsequently Nagasue et al. (1985) have shown raised levels of AR in hepatocellular carcinoma compared to cirrhotic liver. In the data from Nagasue et al., cirrhotic liver appears to have reduced levels of AR compared to normal liver. In the present experiments we have studied tissue which is dysplastic but not macroscopically malignant thus it might be that a reduction in AR occurs as an integral part of the premalignant phase of tumour induction, with a subsequent rise in tissue AR once the tumour is established. An alternative explanation is that AR levels are reduced in a non-specific manner by tissue damage and then become expressed during the process of carcinogenesis. This concept is supported by the fact that liver AR are also reduced in hepatic steatosis of either congenital (Bannister & Whitaker, 1985) or alcohol induced aetiology (Eagon et al., 1985) , or in simple chronic active hepatitis without cirrhosis (Nagasue et al., 1985 oral contraceptive-associated hepatic adenoma. No studies have been performed on ER levels during the pre-malignant phase of tumour production but in a single case report ER levels were increased in focal nodular hyperplasia (Porter et al., 1983b) . Thus an increase in ER and a fall in AR may be important events in hepatic carcinogenesis. The presence of an androgen receptor in female rat liver has not been previously reported. AR levels are a mean of 34% of male AR values. No further reduction in this value was noted after DEN treatment. This failure of AR levels to fall after DEN treatment may reflect lack of sensitivity of the assay or may be a genuine finding. Does the finding of AR in liver have clinical implications? In humans the incidence of hepatocellular carcinomas is increased in males (Nagasue et al., 1984) , suggesting this may be a hormone-dependent tumour.
